# NeOnc Technologies Holdings, Inc. (NTHI)

> Source: Nexqual · https://nexqual.com/NTHI · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, NeOnc Technologies Holdings, Inc. (NTHI), nexqual.com/NTHI" · informational, not investment advice.

**Price:** USD 2.75 (+3.38% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.66 · day 2.67–2.8 · 52w 2.5–12 · market cap $79.2M · NGM

## Key facts
- Analysts: Buy (mean 1.75 on a 1–5 scale) (4 analysts), mean target USD 17 (range 13–20).
- Total return with dividends: 1Y -73.8% vs S&P 500 +18.1%; 5Y -83.4% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.27, revenue estimate $0K.

## Analysts
Consensus Buy (mean 1.75 on a 1–5 scale), 4 analysts; mean target USD 17 (low 13, high 20).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-24 | Roth Capital | Initiated | Buy | $20 |
| 2026-09-08 | BTIG | Reiterated | Buy | $15 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2025-03-24) |
|---|---|---|
| Total return | -73.8% | -83.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -73.9% | -68.3% |
| Volatility (annualized) | 111.3% | 119.9% |
| Max drawdown | -78.6% (Nov 2025→Oct 2026) | -83.4% (Mar 2025→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/NTHI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt